BoYu Innovative freeze-dried human rabies vaccine was approved for clinical treatment.

Introduction: Sino-Biotech and Paotke jointly declared the vaccine system with rabies virus fixed strains inoculated with serum-free Vero cells made of July 23, Bo-Wei Innovation announced that the company's holding company, Zhongke Biopharmaceutical Co., Ltd. and Chengdu Paotke Biotech Co., Ltd. signed a "project cooperation contract" in January 2020 to jointly declare freeze-dried human rabies vaccine (no serum-roro cell) products.
the product was recently approved by the State Drug Administration to issue the "Drug Clinical Trial Approval Notice."
the freeze-dried human rabies vaccine (no serum Vero cells) jointly declared by Sino-Kobio and Paotke, made with rabies virus fixation strains inoculated with serum-free Vero cells, with no serum, no animal-derived ingredients added characteristics, can effectively avoid product use of allergies, fever and other adverse reactions.
indications are: Where a rabies or other mad animal, scratched, according to the post-exposure immunization procedure to inject the vaccine, where there is a risk of exposure to rabies virus vaccination under the pre-exposure immune procedure.
.